Intravascular Ultrasound for Hepatocellular Carcinoma Staging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00474734
Recruitment Status : Unknown
Verified May 2007 by University Hospital, Geneva.
Recruitment status was:  Recruiting
First Posted : May 17, 2007
Last Update Posted : May 17, 2007
Information provided by:
University Hospital, Geneva

Brief Summary:

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.

Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.

As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.

Condition or disease Intervention/treatment
Hepatocellular Carcinoma Device: Intravascular ultrasound of the liver

Study Type : Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study
Study Start Date : May 2007
Estimated Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • hepatocellular carcinoma nodules
  • patient on liver transplantation waiting list
  • written informed consent

Exclusion Criteria:

  • thrombosis of hepatic veins or vena cava

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00474734

Contact: Antoine Hadengue, Prof. +41 22 37 29 340

University Hospital Geneva Recruiting
Geneva, Switzerland
Contact: Andrea De Gottardi, MD PhD    +41 22 37 29 256   
Sponsors and Collaborators
University Hospital, Geneva
Study Chair: Antoine Hadengue, Prof. University Hospital, Geneva Identifier: NCT00474734     History of Changes
Obsolete Identifiers: NCT00472979
Other Study ID Numbers: 07-063
First Posted: May 17, 2007    Key Record Dates
Last Update Posted: May 17, 2007
Last Verified: May 2007

Keywords provided by University Hospital, Geneva:
hepatocellular carcinoma
liver transplantation
intravascular ultrasound

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases